Diamyd Logo
This website is only intended for investors

Fighting diabetes

Diamyd Medical is a diabetes company active in the field of pharmaceutical development. The Company is headquartered in Stockholm, Sweden and shares are listed on NASDAQ OMX First North (ticker: DMYD B).
With the new venture Diamyd Medical enters the expansive field of stem cells.
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
Recent times have been eventful for Diamyd Medical and we were able to report two items of good news in quick succession the past week. Together with a group of founding partners and Karolinska Institutet...
Diamyd® is a GAD-based therapy under development for the treatment and prevention of autoimmune diabetes such as type 1 diabetes and LADA. Treatment with Diamyd® aims to intervene in the autoimmune...
rss icon
    
pdf icon
09 april 2014, 08:30
Delårsrapport II 13/14